NCT03528252 (MYDICLIN) is a NA clinical trial of Written advice LDL Cholesterol in Cholesterol, LDL, sponsored by Uppsala University.

Who is sponsoring NCT03528252?

NCT03528252 is sponsored by Uppsala University.

What drugs are being tested in NCT03528252?

Interventions in NCT03528252: Written advice LDL Cholesterol, Written advice Triglycerides.

What condition does NCT03528252 study?

NCT03528252 studies Cholesterol, LDL.

Is NCT03528252 still recruiting?

NCT03528252 is currently completed. Last updated 26 April 2019.

Last reviewed 2019-04-26 · How we verify

NCT03528252: MYDICLIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Written Dietary Advice on Lipoproteins - a Pragmatic Randomized Controlled Trial

Completed NA Last updated 26 April 2019

What this trial tests

NA trial testing Written advice LDL Cholesterol in Cholesterol, LDL in 113 participants. Completed in 18 April 2019.

Timeline

16 May 2018

Primary endpoint
18 April 2019

18 April 2019

Quick facts

Lead sponsor	Uppsala University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	113
Start date	16 May 2018
Primary completion	18 April 2019
Estimated completion	18 April 2019
Sites	1 location across Sweden

Drugs / interventions tested

Written advice LDL Cholesterol
Written advice Triglycerides

Conditions studied

Cholesterol, LDL — all drugs for Cholesterol, LDL →

Sponsor

Uppsala University

Who can join

Adults 18 to 99, any sex, with Cholesterol, LDL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effect of detailed, written dietary advice for improving blood lipids, in a primary care setting. n=222 participants will be randomized to Active Intervention or Control Group. After 3 weeks' intervention, participants will receive written feedback on the effect on their blood lipids. After 6 months, another blood sample is drawn and participants will receive further written feedback.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of Written Dietary Advice for Improving Blood Lipids in Primary Care Adults-A Pragmatic Randomized Controlled Trial (MYDICLIN).
Rydell A, Hellsten M, Lindow M, Iggman D. · · 2022 · cited 2× · PMID 35267997 · DOI 10.3390/nu14051022

Verify or expand the search:

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03528252 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 26 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03528252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing